Legal Representation
Attorney
Christine M. Baker
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 17, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 17, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 25, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 11, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 14, 2005 | I | PAPER RECEIVED | Loading... | |
| Aug 10, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 10, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 12, 2004 | I | PAPER RECEIVED | Loading... | |
| Jul 30, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Mar 19, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 13, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 13, 2004 | FAXX | I | FAX RECEIVED | Loading... |
| Aug 12, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 12, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 12, 2003 | FAXX | I | FAX RECEIVED | Loading... |
| Mar 20, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 20, 2002 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 20, 2002 | I | PAPER RECEIVED | Loading... | |
| Aug 13, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 21, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 1, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 30, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 8, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 8, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 3, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Medical diagnostic reagents; biosensors and molecular profiling arrays and assays for medical diagnostic use
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical development and research for others; research and development of new products for others in the fields of pharmaceuticals, drug discovery and diagnostic technologies
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
RIBO REPORTER
Classification
International Classes
005
042